Literature DB >> 27432288

microRNA-199a-3p functions as tumor suppressor by regulating glucose metabolism in testicular germ cell tumors.

Xiaowen Liu1, Hongyan Duan1, Shihua Zhou1, Zhiyong Liu1, Daobing Wu1, Ting Zhao1, Shan Xu2, Lifang Yang2, Dan Li1.   

Abstract

microRNA (miR)-199a-3p serves critical roles in cancer development and progression. In order to improve knowledge of the functional mechanism of miR‑199a‑3p in testicular tumors, the present study characterized the regulation of aerobic glycolysis by miR‑199a‑3p and its impact on metabolism. Using 3‑4,5‑dimethylthiazol‑2‑yl‑2,5 diphenyl tetrazolium bromide, wound healing and flow cytometry assays, it was determined that overexpression of miR‑199a‑3p in Ntera‑2 cells caused suppression of cell growth and migration. Further biochemical methods and high‑throughput quantitative polymerase chain reaction array of metabolic genes showed that inhibition of miR‑199a‑3p markedly elevated lactate production and 12 differentially expressed genes, including 2 upregulated and 10 downregulated genes, were identified following treatment with miR‑199a‑3p in Ntera‑2 cells. In clinical samples, four selected genes, lactate dehydrogenase A, monocarboxylate transporter 1, phosphoglycerate kinase 1 and TP53‑inducible glycolysis and apoptosis regulator, were significantly overexpressed in malignant testicular germ cell tumor, and their expression inversely correlated with the expression of miR‑199a‑3p, suggesting that these four genes may be affected by miR‑199a‑3p. Using bioinformatics analysis, the transcription factor Sp1 binding site was identified in the promoter region of the four selected genes. In addition, miR‑199a‑3p was predicted to bind to conservative target sequences in the 3'‑untranslated region of Sp1 mRNA, suggesting that miR-199a-3p may downregulate these four metabolic genes through Sp1. It was demonstrated the dysregulated expression and activation of miR‑199a‑3p may serve important roles in aerobic glycolysis and tumorigenesis in patients with testicular cancer. Therefore, miR-199a-3p may be a potential biomarker in the prognosis and treatment of testicular tumors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27432288     DOI: 10.3892/mmr.2016.5472

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  11 in total

1.  MicroRNA-429 inhibits gastric cancer migration and invasion through the downregulation of specificity protein 1.

Authors:  Jingbin Ni; Yisha Yang; Di Liu; Hui Sun; Shimao Jin; Jingying Li
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

2.  MicroRNA-199a-3p attenuates hepatic lipogenesis by targeting Sp1.

Authors:  Yang Cheng; Li Huang; Jian Ping; Tianyang Chen; Jianjie Chen
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

3.  hsa-miR-199a-3p Inhibits Motility, Invasiveness, and Contractility of Ovarian Endometriotic Stromal Cells.

Authors:  Ruofei Zhu; Kaei Nasu; Naoki Hijiya; Masato Yoshihashi; Tomoko Hirakawa; Yoko Aoyagi; Hisashi Narahara
Journal:  Reprod Sci       Date:  2021-05-13       Impact factor: 3.060

Review 4.  Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.

Authors:  Run-Ze Shang; Shi-Bin Qu; De-Sheng Wang
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

5.  Identification of key genes and pathways in seminoma by bioinformatics analysis.

Authors:  Ye-Hui Chen; Ting-Ting Lin; Yu-Peng Wu; Xiao-Dong Li; Shao-Hao Chen; Xue-Yi Xue; Yong Wei; Qing-Shui Zheng; Jin-Bei Huang; Ning Xu
Journal:  Onco Targets Ther       Date:  2019-05-14       Impact factor: 4.147

6.  Downregulation of miR-199a-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism via GEO, TCGA Database and In Silico Analyses.

Authors:  An-Gui Liu; Yu-Yan Pang; Gang Chen; Hua-Yu Wu; Rong-Quan He; Yi-Wu Dang; Zhi-Guang Huang; Rui Zhang; Jie Ma; Li-Hua Yang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.

Authors:  Yu Zhang; Qian Yan; Lanqi Gong; Hang Xu; Beilei Liu; Xiaona Fang; Dandan Yu; Lei Li; Ting Wei; Ying Wang; Ching Ngar Wong; Zhaojie Lyu; Ying Tang; Pak Chung Sham; Xin-Yuan Guan
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

8.  CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients.

Authors:  Thomas Greither; Alice Wedler; Swetlana Rot; Jacqueline Keßler; Astrid Kehlen; Hans-Jürgen Holzhausen; Matthias Bache; Peter Würl; Helge Taubert; Matthias Kappler
Journal:  Int J Mol Sci       Date:  2017-12-07       Impact factor: 5.923

Review 9.  MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.

Authors:  Natalia García-Sancha; Roberto Corchado-Cobos; Jesús Pérez-Losada; Javier Cañueto
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

Review 10.  Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.

Authors:  Manuel Regouc; Gazanfer Belge; Anja Lorch; Klaus-Peter Dieckmann; Martin Pichler
Journal:  Cancers (Basel)       Date:  2020-03-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.